Serotonin 5-HT3 Receptor-Mediated Vomiting Occurs via the Activation of Ca2+/CaMKII-Dependent ERK1/2 Signaling in the Least Shrew (Cryptotis parva) | PLOS ONE
Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties | Journal of Medicinal Chemistry
![Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties | Journal of Medicinal Chemistry Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00224/asset/images/large/jm1c00224_0020.jpeg)
Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties | Journal of Medicinal Chemistry
FPGEETutor.com - A 67-year-old woman is receiving chemotherapy for metastatic ovarian cancer. She is on her fourth cycle of a multi-drug regimen, including cisplatin and doxorubicin. She has developed nausea and vomiting,
![Antiemetic Drugs (Part-06 Final) = Mechanism of Action of 5HT3 Antagonist (Ondansetron)| Ondansetron - YouTube Antiemetic Drugs (Part-06 Final) = Mechanism of Action of 5HT3 Antagonist (Ondansetron)| Ondansetron - YouTube](https://i.ytimg.com/vi/JKthJVOIRKM/maxresdefault.jpg)
Antiemetic Drugs (Part-06 Final) = Mechanism of Action of 5HT3 Antagonist (Ondansetron)| Ondansetron - YouTube
![5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials | Pithadia | Journal of Clinical Medicine Research 5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials | Pithadia | Journal of Clinical Medicine Research](https://www.jocmr.org/tables/jocmr2009.05.1237-g001.jpg)
5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials | Pithadia | Journal of Clinical Medicine Research
![5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface | Pharmacological Reviews 5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/71/3/383/F2.large.jpg)
5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface | Pharmacological Reviews
![Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine | CNS Spectrums | Cambridge Core Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine | CNS Spectrums | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20160710181748-64510-mediumThumb-S1092852915000346_fig5g.jpg?pub-status=live)
Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine | CNS Spectrums | Cambridge Core
![Molecular mechanism of setron-mediated inhibition of full-length 5-HT3A receptor | Nature Communications Molecular mechanism of setron-mediated inhibition of full-length 5-HT3A receptor | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-019-11142-8/MediaObjects/41467_2019_11142_Fig1_HTML.png)
Molecular mechanism of setron-mediated inhibition of full-length 5-HT3A receptor | Nature Communications
![Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine | CNS Spectrums | Cambridge Core Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine | CNS Spectrums | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary-alt:20160710181748-21215-mediumThumb-S1092852915000346_fig2g.jpg?pub-status=live)